A detailed history of Franklin Resources Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Franklin Resources Inc holds 10,155 shares of IONS stock, worth $368,931. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,155
Previous 10,155 -0.0%
Holding current value
$368,931
Previous $406,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$40.06 - $51.86 $5,327 - $6,897
133 Added 1.33%
10,155 $406,000
Q2 2024

Aug 14, 2024

BUY
$36.45 - $47.7 $7,763 - $10,160
213 Added 2.17%
10,022 $477,000
Q1 2024

May 13, 2024

SELL
$42.03 - $53.55 $163,748 - $208,630
-3,896 Reduced 28.43%
9,809 $425,000
Q4 2023

Feb 09, 2024

BUY
$43.39 - $51.63 $228,057 - $271,367
5,256 Added 62.21%
13,705 $693,000
Q3 2023

Nov 13, 2023

SELL
$38.5 - $47.13 $27,797 - $34,027
-722 Reduced 7.87%
8,449 $383,000
Q2 2023

Aug 11, 2023

SELL
$34.73 - $43.33 $42,683 - $53,252
-1,229 Reduced 11.82%
9,171 $376,000
Q1 2023

May 12, 2023

SELL
$33.58 - $41.2 $111,452 - $136,742
-3,319 Reduced 24.19%
10,400 $371,000
Q4 2022

Feb 10, 2023

BUY
$37.12 - $46.52 $91,612 - $114,811
2,468 Added 21.94%
13,719 $518,000
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $411,111 - $547,473
11,251 New
11,251 $497,000
Q1 2021

May 13, 2021

SELL
$42.51 - $63.78 $156,521 - $234,837
-3,682 Closed
0 $0
Q4 2020

Feb 10, 2021

SELL
$45.3 - $60.27 $10.8 Million - $14.4 Million
-238,669 Reduced 98.48%
3,682 $208,000
Q3 2020

Nov 12, 2020

BUY
$47.45 - $62.95 $100,641 - $133,516
2,121 Added 0.88%
242,351 $11.5 Million
Q2 2020

Aug 13, 2020

SELL
$46.85 - $61.05 $20,754 - $27,045
-443 Reduced 0.18%
240,230 $14.6 Million
Q1 2020

May 13, 2020

SELL
$41.6 - $63.4 $953,763 - $1.45 Million
-22,927 Reduced 8.7%
240,673 $11.4 Million
Q2 2019

Aug 14, 2019

SELL
$62.09 - $86.14 $9.59 Million - $13.3 Million
-154,400 Reduced 36.94%
263,600 $16.9 Million
Q1 2019

May 14, 2019

BUY
$52.92 - $81.17 $14.2 Million - $21.8 Million
268,820 Added 180.2%
418,000 $33.9 Million
Q4 2018

Feb 12, 2019

SELL
$43.37 - $59.54 $14.8 Million - $20.3 Million
-341,394 Reduced 69.59%
149,180 $8.07 Million
Q3 2018

Nov 13, 2018

SELL
$42.88 - $53.7 $9.71 Million - $12.2 Million
-226,442 Reduced 31.58%
490,574 $25.3 Million
Q2 2018

Aug 14, 2018

SELL
$40.53 - $50.7 $921,652 - $1.15 Million
-22,740 Reduced 3.07%
717,016 $29.9 Million
Q1 2018

May 10, 2018

SELL
$44.08 - $55.05 $480,912 - $600,595
-10,910 Reduced 1.45%
739,756 $32.6 Million
Q4 2017

Feb 14, 2018

SELL
$50.3 - $64.39 $8.87 Million - $11.4 Million
-176,302 Reduced 19.02%
750,666 $37.8 Million
Q3 2017

Nov 13, 2017

BUY
$45.56 - $59.57 $42.2 Million - $55.2 Million
926,968
926,968 $47 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.16B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.